EcoDrugPlus

Endothelin Receptor Type B

Ensembl ID : ENSCGOG00000022493
Gene Symbol: EDNRB
1 Cross references
200 Possible Orthologues:

Endothelin Receptor Type B-Like

Ensembl ID : ENSCGOG00000014273
Gene Symbol: LOC115023544
3 Cross references
201 Possible Orthologues:

Epidermal Growth Factor Receptor-Like

Ensembl ID : ENSCGOG00000017349
Gene Symbol: LOC115022485
3 Cross references
212 Possible Orthologues:

Equilibrative Nucleoside Transporter 1-Like

Ensembl ID : ENSCGOG00000018601
Gene Symbol: LOC115019715
3 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSCGOG00000002634
Gene Symbol: ERBB3
3 Cross references
210 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSCGOG00000018283
Gene Symbol: ERBB4
3 Cross references
222 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSCGOG00000006892
Gene Symbol: ESR1
3 Cross references
215 Possible Orthologues:

Estrogen Receptor Beta

Ensembl ID : ENSCGOG00000019318
Gene Symbol: LOC115005054
3 Cross references
207 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSCGOG00000009032
Gene Symbol: LOC115028997
3 Cross references
200 Possible Orthologues:

Estrogen-Related Receptor Gamma

Ensembl ID : ENSCGOG00000021295
Gene Symbol: LOC115028202
3 Cross references
203 Possible Orthologues:

Exportin 1

Ensembl ID : ENSCGOG00000004030
Gene Symbol: XPO1
3 Cross references
217 Possible Orthologues:

Exportin 1

Ensembl ID : ENSCGOG00000000002
Gene Symbol: XPO1
3 Cross references
229 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).